The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
Open accessAbstract
We investigated SARS-CoV-2 potential tropism by surveying expression of viral entry-associated genes in single-cell RNA-sequencing data from multiple tissues from healthy human donors. We co-detected these transcripts in specific respiratory, corneal and intestinal epithelial cells, potentially explaining the high efficiency of SARS-CoV-2 transmission. These genes are co-expressed in nasal epithelial cells with genes involved in innate immunity, highlighting the cells’ potential role in initial viral infection, spread and clearance. The study offers a useful resource for further lines of inquiry with valuable clinical samples from COVID-19 patients and we provide our data in a comprehensive, open and user-friendly fashion at www.covid19cellatlas.org . An analysis of single-cell transcriptomics datasets from different tissues shows that ACE2 and TMPRSS2 are co-expressed in respiratory, corneal and intestinal epithelial cell populations, and that respiratory expression of ACE2 is associated with genes involved in innate immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although scSeq revealed ACE2 transcripts in only a subset of OE cells, this low level of observed expression matches or exceeds that observed in respiratory cells types that are infected by CoV-2 in COVID-19 patients (39) (Fig. 3).”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [39]
Experimental — accuracy not yet measuredIn the citing paper
“Probably most important for the high efficacy of SARS-CoV-2 transmission is the high co-expression of ACE2 and TMPRSS2 in nasal epithelial cells, particularly in two types of goblet cells and a subset of ciliated cells, showing the highest expression among all cells in the respiratory tree (Figure 2 A).”
From COVID-19 and the human innate immune system (2021) · cites this paper as Sungnak et al., 2020
In the citing paper
“An interesting observation of this study was the high co-expression of genes involved in early steps of antiviral immune responses in these epithelial cells, which indicated the potential for these specialized nasal cells to play an important role in the initial viral infection, spread, but potentially also, clearance.”
From COVID-19 and the human innate immune system (2021) · cites this paper as Sungnak et al., 2020
In the citing paper
“TMPRSS2 is more widely expressed than ACE2, and cells with simultaneous expression were identified in the respiratory tree, the cornea, esophagus, ileum, colon, gallbladder, and common bile duct (Sungnak et al., 2020), yet there was no evidence for simultaneous expression in immune cells.”
From COVID-19 and the human innate immune system (2021) · cites this paper as Sungnak et al., 2020
In the citing paper
“It has recently been demonstrated through single cell RNA sequencing analysis (referred to herein as scSeq) that cells from the human upper airway — including nasal RE goblet and ciliated cells —express high levels of ACE2 and TMPRSS2, suggesting that these RE cell types may serve as a viral reservoir during CoV-2 infection (39, 40).”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Clinical Characteristics of Coronavirus Disease 2019 in China
Eastin, C., & Eastin, T. (2020) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2020.04.004 · Cited by 24,945
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Fast, sensitive and accurate integration of single-cell data with Harmony
Korsunsky, I., Millard, N., Fan, J., Slowikowski, K., Zhang, F., Wei, K., Baglaenko, Y., Brenner, M., Loh, P.-R., & Raychaudhuri, S. (2019) · Nature Methods · doi:10.1038/s41592-019-0619-0 · Cited by 10,488
Cited by
Sorted by citations
Items 401–500 of 1,000
Li, L., Honda‐Okubo, Y., Huang, Y., Jang, H., Carlock, M. A., Baldwin, J., Piplani, S., Bebin-Blackwell, A.-G., Forgacs, D., Sakamoto, K., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.07.087 · Cited by 71
Wehbe, Z., Hammoud, S. H., Soudani, N., Zaraket, H., EL‐Yazbi, A. F., & Eid, A. H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00836 · Cited by 71
Xi, J., Si, X. A., & Nagarajan, R. (2020) · Physics of Fluids · doi:10.1063/5.0034580 · Cited by 72
Ocular manifestations in COVID-19 patients: A systematic review and meta-analysis
Zhong, Y., Wang, K., Zhu, Y., Lyu, D., Yu, Y., Li, S., & Yao, K. (2021) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2021.102191 · Cited by 71
COVID-19 — Toward a comprehensive understanding of the disease
Kowalik, M. M., Trzonkowski, P., Łasińska-Kowara, M., Mital, A., Smiatacz, T., & Jaguszewski, M. J. (2020) · Cardiology Journal · doi:10.5603/cj.a2020.0065 · Cited by 71
Briguglio, M., Bona, A. R., Porta, M., Dell’Osso, B. M., Pregliasco, F. E., & Banfi, G. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00671 · Cited by 70
Guo, J., Wei, X., Li, Q., Li, L., Yang, Z., Shi, Y., Qin, Y., Zhang, X., Wang, X., Zhi, X., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29802 · Cited by 70
Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus
Omolo, C. A., Soni, N., Fasiku, V. O., Mackraj, I., & Govender, T. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173348 · Cited by 69
Autoimmunity as the comet tail of COVID-19 pandemic
Talotta, R., & Robertson, E. S. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i17.3621 · Cited by 69
Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms
Khan, M. A., Khan, Z. A., Charles, M. R., Pratap, P. D., Naeem, A., Siddiqui, Z., Naqvi, N., & Srivastava, S. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s271292 · Cited by 71
Direct derivation of human alveolospheres for SARS-CoV-2 infection modeling and drug screening
Ebisudani, T., Sugimoto, S., Haga, K., Mitsuishi, A., Takai‐Todaka, R., Fujii, M., Toshimitsu, K., Hamamoto, J., Sugihara, K., Hishida, T., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109218 · Cited by 69
Moakes, R. J. A., Davies, S. P., Stamataki, Z., & Grover, L. M. (2021) · Advanced Materials · doi:10.1002/adma.202008304 · Cited by 69
A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions
Neerukonda, S. N., & Katneni, U. (2020) · Pathogens · doi:10.3390/pathogens9060426 · Cited by 70
Salmon, D., Bartier, S., Hautefort, C., Nguyen, Y., Nevoux, J., Hamel, A.-L., Camhi, Y., Canouï‐Poitrine, F., Vérillaud, B., Slama, D., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.07.005 · Cited by 68
Kumar, A., Pareek, V., Prasoon, P., Faiq, M. A., Kumar, P., Kumari, C., & Narayan, R. K. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24717 · Cited by 67
COVID-19: Proposing a Ketone-Based Metabolic Therapy as a Treatment to Blunt the Cytokine Storm
Bradshaw, P. C., Seeds, W. A., Miller, A. C., Mahajan, V. R., & Curtis, W. M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6401341 · Cited by 73
Roberts, J., Pritchard, A. L., Treweeke, A. T., Rossi, A. G., Brace, N., Cahill, P. A., MacRury, S. M., Wei, J., & Megson, I. L. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.629933 · Cited by 68
SARS-CoV-2 Infection of Airway Epithelial Cells
Ryu, G., & Shin, H. (2021) · Immune Network · doi:10.4110/in.2021.21.e3 · Cited by 74
Rhoades, N. S., Pinski, A. N., Monsibais, A. N., Jankeel, A., Doratt, B. M., Cinco, I. R., Ibraim, I. C., & Messaoudi, I. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109637 · Cited by 73
COVID-19 Mechanisms in the Human Body—What We Know So Far
Kumar, A., Narayan, R. K., Prasoon, P., Kumari, C., Kaur, G., Kumar, S., Kulandhasamy, M., Sesham, K., Pareek, V., Faiq, M. A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.693938 · Cited by 76
Schuhenn, J., Meister, T. L., Tödt, D., Bracht, T., Schork, K., Billaud, J.-N., Elsner, C., Heinen, N., Karakoese, Z., Haid, S., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111600119 · Cited by 72
Advances and future perspectives of intranasal drug delivery: A scientometric review
Xu, D. W., Song, X., Chen, X., Wang, J., & Cui, Y. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.01.053 · Cited by 68
Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract
Lee, J. J., Kopetz, S., Vilar, E., Shen, J. P., Chen, K., & Maitra, A. (2020) · Genes · doi:10.3390/genes11060645 · Cited by 67
Pierce, J. B., Simion, V., Icli, B., Pérez‐Cremades, D., Cheng, H. S., & Feinberg, M. W. (2020) · Genes · doi:10.3390/genes11111354 · Cited by 68
Presence of SARS-CoV-2 RNA in the Cornea of Viremic Patients With COVID-19
Casagrande, M. K., Fitzek, A., Spitzer, M. S., Püschel, K., Glatzel, M., Krasemann, S., Nörz, D. S., Lütgehetmann, M., Pfefferle, S., & Schultheiß, M. (2021) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2020.6339 · Cited by 67
Effects of Environmental Factors on Severity and Mortality of COVID-19
Kifer, D., Bugada, D., Villar-García, J., Gudelj, I., Menni, C., Sudre, C. H., Vučković, F., Ugrina, I., Lorini, F. L., Posso, M., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.607786 · Cited by 68
Integrin activation is an essential component of SARS-CoV-2 infection
Simons, P. C., Rinaldi, D. A., Bondu, V., Kell, A. M., Bradfute, S. B., Lidke, D. S., & Buranda, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-99893-7 · Cited by 69
Sarubbo, F., Haji, K. E., Vidal-Balle, A., & Bargay, J. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100399 · Cited by 71
Single cell atlas for 11 non-model mammals, reptiles and birds
Chen, D., Sun, J. G., Zhu, J., Ding, X., Lan, T., Wang, X., Wu, W., Ou, Z., Zhu, L., Ding, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27162-2 · Cited by 68
Are we underestimating seroprevalence of SARS-CoV-2?
Burgess, S., Ponsford, M., & Gill, D. (2020) · BMJ · doi:10.1136/bmj.m3364 · Cited by 67
How to perform a nasopharyngeal swab in adults and children in the COVID-19 era
Pondaven-Letourmy, S., Alvin, F., Boumghit, Y., & Simon, F. (2020) · European Annals of Otorhinolaryngology Head and Neck Diseases · doi:10.1016/j.anorl.2020.06.001 · Cited by 69
Could Ergothioneine Aid in the Treatment of Coronavirus Patients?
Cheah, I. K.-M., & Halliwell, B. B. (2020) · Antioxidants · doi:10.3390/antiox9070595 · Cited by 67
Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface
Roehrich, H., Yuan, C., & Hou, J. H. (2020) · Cornea · doi:10.1097/ico.0000000000002509 · Cited by 66
Smell and Taste in Severe CoViD-19: Self-Reported vs. Testing
Mazzatenta, A., Neri, G., D’Ardes, D., Luca, C. D., Marinari, S., Porreca, E., Cipollone, F., Vecchiet, J., Falcicchia, C., Panichi, V., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.589409 · Cited by 66
Ambike, S. S., Cheng, C., Feuerherd, M., Velkov, S., Baldassi, D., Afridi, S. Q., Porras-Gonzalez, D., Wei, X. C., Hagen, P., Kneidinger, N., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1248 · Cited by 73
Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2
Xia, B., Pan, X., Luo, R., Shen, X., Li, S., Wang, Y., Zuo, X., Wu, Y. L., Guo, Y., Xiao, G., et al. (2023) · Cell Discovery · doi:10.1038/s41421-022-00510-2 · Cited by 67
Schütz, D., Conzelmann, C., Fois, G., Groß, R. M., Weil, T., Wettstein, L., Stenger, S., Zelikin, A. N., Hoffmann, T. K., Frick, M., et al. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00552.2020 · Cited by 70
Robson, B. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.103849 · Cited by 65
Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19
Liu, P., Cai, J., Jia, R., Xia, S., Wang, X., Cao, L., Zeng, M., & Xu, J. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1772677 · Cited by 65
Suručić, R. V., Tubić, B., Stojiljković, M. P., Djuric, D. M., Travar, M., Grabež, M., Šavikin, K., & Škrbić, R. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03981-7 · Cited by 65
Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2
Zhao, H., To, K. K., Lam, H., Zhou, X., Chan, J. F., Peng, Z., Lee, A. C.-Y., Cai, J., Chan, W.-M., Ip, J. D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21825-w · Cited by 67
Welcome, M. O., & Mastorakis, N. E. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00806-x · Cited by 66
Dynamic human liver proteome atlas reveals functional insights into disease pathways
Niu, L., Geyer, P. E., Gupta, R., Santos, A., Meier, F., Doll, S., Albrechtsen, N. J. W., Klein, S., Ortiz, C., Uschner, F. E., et al. (2022) · Molecular Systems Biology · doi:10.15252/msb.202210947 · Cited by 67
COVID‐19: Focus on the lungs but do not forget the gastrointestinal tract
Smyk, W., Janik, M. K., Portincasa, P., Milkiewicz, P., Lammert, F., & Krawczyk, M. J. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13276 · Cited by 64
Lippi, G., Lavie, C. J., Henry, B. M., & Sanchis‐Gomar, F. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0727 · Cited by 64
Wang, Z., Zhou, J., Marshall, B., Rekaya, R., Ye, K., & Liu, H. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00062 · Cited by 64
ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection
Descamps, G., Verset, L., Trelcat, A., Hopkins, C. L., Lechien, J. R., Journé, F., & Saussez, S. (2020) · Biology · doi:10.3390/biology9080235 · Cited by 65
Neurological manifestations in COVID-19: A narrative review
Rahman, A., Niloofa, R., Zoysa, I. D., Cooray, A., Kariyawasam, J., & Seneviratne, S. L. (2020) · SAGE Open Medicine · doi:10.1177/2050312120957925 · Cited by 64
Viral infection and smell loss: The case of COVID‐19
Glezer, I., Bruni‐Cardoso, A., Schechtman, D., & Malnic, B. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15197 · Cited by 69
Exosome therapeutics for COVID‐19 and respiratory viruses
Popowski, K. D., Dinh, P., George, A., Lutz, H., & Cheng, K. (2021) · Open Research (University of Surrey) · doi:10.1002/viw.20200186 · Cited by 64
Aleksova, A., Gagno, G., Sinagra, G., Beltrami, A. P., Janjusevic, M., Ippolito, G., Zumla, A. I., Fluca, A. L., & Ferro, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094526 · Cited by 64
CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses
Jalloh, S., Olejnik, J., Berrigan, J. L., Nisa, A., Suder, E. L., Akiyama, H., Lei, M., Ramaswamy, S., Tyagi, S., Bushkin, Y., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010479 · Cited by 69
Molecular mechanisms and epidemiology of COVID-19 from an allergist’s perspective
Hosoki, K., Chakraborty, A., & Sur, S. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.033 · Cited by 63
Central Nervous System Targets and Routes for SARS-CoV-2: Current Views and New Hypotheses
Barrantes, F. J. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00434 · Cited by 65
The Inflammatory Profile of Obesity and the Role on Pulmonary Bacterial and Viral Infections
Hornung, F., Rogal, J., Loskill, P., Löffler, B., & Deinhardt‐Emmer, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073456 · Cited by 63
Oral Pathology in COVID-19 and SARS-CoV-2 Infection—Molecular Aspects
Droździk, A., & Droździk, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031431 · Cited by 66
İdilman, İ. S., Dizman, G. T., Düzgün, S. A., Irmak, İ., Karçaaltıncaba, M., İnkaya, A. Ç., Demirkazık, F., Durhan, G., Akpınar, M. G., Arıyürek, O. M., et al. (2020) · European Radiology · doi:10.1007/s00330-020-07155-3 · Cited by 62
ACE2 & TMPRSS2 Expressions in Head & Neck Tissues: A Systematic Review
Lechien, J. R., Radulesco, T., Calvo‐Henríquez, C., Chiesa-Estomba, C. M., Hans, S., Barillari, M. R., Cammaroto, G., Descamps, G., Hsieh, J. W., Vaira, L. A., et al. (2020) · Head and Neck Pathology · doi:10.1007/s12105-020-01212-5 · Cited by 64
Singh, D., Wasan, H., & Reeta, K. H. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.10.016 · Cited by 62
Borges, R. C., Hohmann, M. S., & Borghi, S. M. (2020) · International Reviews of Immunology · doi:10.1080/08830185.2020.1844195 · Cited by 61
Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin
Ouyang, Y., Bagalkot, T. R., Fitzgerald, W., Sadovsky, E., Chu, T., Martínez-Marchal, A., Brieño‐Enríquez, M. A., Su, E. J., Margolis, L. B., Sorkin, A. D., et al. (2021) · mSphere · doi:10.1128/msphere.00250-21 · Cited by 62
Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19
Liu, J., Liu, S., Zhang, Z., Lee, X., Wu, W., Huang, Z., Lei, Z., Xu, W., Chen, D., Wu, X., et al. (2021) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2021.06.002 · Cited by 64
Liu, Q., Li, S., Dupuy, A., Le, H., Sailliet, N., Logé, C., Robert, J.-M. H., & Brouard, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157763 · Cited by 64
Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients
Zhao, X.-N., You, Y., Cui, X., Gao, H., Wang, G., Zhang, S., Lin, Y., Duan, L., Zhu, K.-L., Wang, Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00753-7 · Cited by 64
SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters
Qiao, W., Lau, H. E., Xie, H., Poon, V. K., Chan, C. C., Chu, H., Yuan, S., Yuen, T. T., Chik, K. K., Tsang, J. O., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30195-w · Cited by 62
Evolution of Olfactory Disorders in COVID ‐19 Patients
Gorzkowski, V., Bevilacqua, S., Charmillon, A., Jankowski, R., Gallet, P., Rumeau, C., & Nguyen, D. T. (2020) · The Laryngoscope · doi:10.1002/lary.28957 · Cited by 62
Zeng, H., Ma, Y., Zhou, Z., Liu, W., Huang, P., Jiang, M., Liu, Q., Chen, P., Luo, H., & Chen, Y. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.645651 · Cited by 61
COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform
Ashraf, M. U., Kim, Y., Kumar, S., Seo, D., Ashraf, M., & Bae, Y. (2021) · Vaccines · doi:10.3390/vaccines9020171 · Cited by 62
Gaussen, A., Hornby, L., Rockl, G., O’Brien, S. F., Delage, G., Sapir‐Pichhadze, R., Drews, S. J., Weiss, M. J., & Lewin, A. (2021) · Transplantation · doi:10.1097/tp.0000000000003744 · Cited by 62
Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2
Prévost, J., Richard, J., Gasser, R., Ding, S., Fage, C., Anand, S. P., Adam, D., Vergara, N. G., Tauzin, A., Benlarbi, M., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101151 · Cited by 64
Nonmuscle myosin heavy chain IIA facilitates SARS-CoV-2 infection in human pulmonary cells
Chen, J., Fan, J., Chen, Z., Zhang, M., Peng, H., Jian, L., Ding, L., Liu, M., Zhao, C., Zhao, P., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111011118 · Cited by 59
Alam, S. B., Willows, S. D., Kulka, M., & Sandhu, J. K. (2020) · European Journal of Neurology · doi:10.1111/ene.14442 · Cited by 61
Kumar, A., Faiq, M. A., Pareek, V., Raza, K., Narayan, R. K., Prasoon, P., Kumar, P., Kulandhasamy, M., Kumari, C., Kant, K., et al. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110271 · Cited by 61
Lee, S. W., Kim, S. Y., Moon, S. Y., Yang, J. M., Ha, E. K., Jee, H. M., Shin, J. I., Cho, S., Yon, D. K., & Suh, D. I. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.03.044 · Cited by 61
The eye as the discrete but defensible portal of coronavirus infection
Coroneo, M. T. (2020) · The Ocular Surface · doi:10.1016/j.jtos.2020.05.011 · Cited by 62
Nanomedicine strategies to target coronavirus
Heinrich, M. A., Martina, B. E. E., & Prakash, J. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100961 · Cited by 60
SARS-CoV-2: Targeted managements and vaccine development
Bakhiet, M., & Taurin, S. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.11.001 · Cited by 65
Mizukoshi, A., Nakama, C., Okumura, J., & Azuma, K. (2020) · Environment International · doi:10.1016/j.envint.2020.106338 · Cited by 59
Classical and alternative receptors for SARS‐CoV‐2 therapeutic strategy
Masre, S. F., Jufri, N. F., Ibrahim, F. W., & Raub, S. H. A. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2207 · Cited by 62
Metabolic Alterations in SARS-CoV-2 Infection and Its Implication in Kidney Dysfunction
Andrade-Silva, M., da Silva, A. R. P. A., do Amaral, M. A., de Fragas, M. G., & Câmara, N. O. S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.624698 · Cited by 60
Loop-Mediated Isothermal Amplification Detection of SARS-CoV-2 and Myriad Other Applications
Moore, K. J. M., Cahill, J., Aidelberg, G., Aronoff, R., Bektaş, A., Bezdan, D., Butler, D., Chittur, S. V., Codyre, M., Federici, F., et al. (2021) · Journal of Biomolecular Techniques JBT · doi:10.7171/jbt.21-3203-017 · Cited by 59
Zhang, L., Jiang, Y., He, J., Chen, J., Qi, R., Yuan, L., Shao, T., Zhao, H. J., Chen, C., Chen, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39560-9 · Cited by 62
The Application of Single‐Cell RNA Sequencing in Vaccinology
Noé, A., Cargill, T. N., Nielsen, C. M., Russell, A. J. C., & Barnes, E. J. (2020) · Journal of Immunology Research · doi:10.1155/2020/8624963 · Cited by 61
Female reproductive tract has low concentration of SARS-CoV2 receptors
Goad, J., Rudolph, J. D., & Rajkovic, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243959 · Cited by 58
Islam, A. B. M. M. K., Khan, M. A., Ahmed, R., Hossain, M. S., Kabir, S. M. T., Islam, M. S., & Siddiki, A. Z. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-020-02695-0 · Cited by 58
N-Acetylcysteine and Hydrogen Sulfide in Coronavirus Disease 2019
Bourgonje, A. R., Offringa, A. K., van Eijk, L. E., Abdulle, A. E., Hillebrands, J., van der Voort, P. H. J., van Goor, H., & Hezik, E. J. V. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8247 · Cited by 58
A systematic review and meta-analysis of effect of vitamin D levels on the incidence of COVID-19
Szarpak, L., Rafique, Z., Gąsecka, A., Chirico, F., Gaweł, W., Hernik, J., Kamińska, H., Filipiak, K. J., Jaguszewski, M. J., & Szarpak, Ł. (2021) · Cardiology Journal · doi:10.5603/cj.a2021.0072 · Cited by 58
Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators
Ricci, D., Etna, M. P., Rizzo, F., Sandini, S., Severa, M., & Coccia, E. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137017 · Cited by 61
Rochette, L., Zeller, M., Cottin, Y., & Vergely, C. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.08.011 · Cited by 58
Gawish, R., Starkl, P. M., Pimenov, L., Hladik, A., Lakovits, K., Oberndorfer, F., Cronin, S. J., Ohradanova‐Repic, A., Wirnsberger, G., Agerer, B., et al. (2022) · eLife · doi:10.7554/elife.74623 · Cited by 61
Lloyd‐Jones, G., Molayem, S., Pontes, C. D. N., & Chapple, I. (2021) · Journal Of Oral Medicine And Dental Research · doi:10.52793/jomdr.2020.2(1)-13 · Cited by 59
Age-specific nasal epithelial responses to SARS-CoV-2 infection
Woodall, M. N. J., Cujba, A.-M., Worlock, K. B., Case, K., Masonou, T., Yoshida, M., Polański, K., Huang, N., Lindeboom, R. G. H., Mamanova, L., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01658-1 · Cited by 61
Self-citationPyrć, K., Milewska, A., Barreto-Durán, E., Botwina, P., Dąbrowska, A., Jędrysik, M., Benedyk‐Machaczka, M., Lopes, R. M., Arenas‐Pinto, A., Badr, M. Y., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99404-8 · Cited by 59
Current Perspective of Antiviral Strategies against COVID-19
Ahidjo, B. A., Loe, M. W. C., Ng, Y. L., Mok, C. K., & Chu, J. J. H. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00236 · Cited by 58
Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19)
Yazdanpanah, N., Saghazadeh, A., & Rezaei, N. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0039 · Cited by 58
SARS-CoV-2 on the ocular surface: is it truly a novel transmission route?
Chen, X., Yu, H., Mei, T., Chen, B., Chen, L., Li, S., Zhang, X., & Sun, X. (2020) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2020-316263 · Cited by 58
Zhang, X. S., & Duchaine, C. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00184-20 · Cited by 59
Riestra‐Ayora, J., Yanes‐Diaz, J., Estéban-Sánchez, J., Vaduva, C., Molina‐Quiros, C., Larrán-Jiménez, A., & Martín-Sanz, E. (2021) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-021-06764-y · Cited by 59
Clinical laboratory evaluation of COVID-19
Chen, Z., Xu, W., Ma, W., Shi, X., Li, S., Hao, M., Fang, Y., & Zhang, L. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.04.022 · Cited by 57
McGonagle, D., Bridgewood, C., & Meaney, J. F. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00213-7 · Cited by 57
Metadata
- Authors
- HCA Lung Biological Network, Sungnak, W., Huang, N., Bécavin, C., Berg, M., Queen, R., Litvinukova, M., Talavera-López, C., Maatz, H., Reichart, D., Sampaziotis, F., Worlock, K. B., Yoshida, M., & Barnes, J. L.
- Affiliations
- Wellcome Sanger Institute (GB)
- Centre National de la Recherche Scientifique (FR)
- University Medical Center Groningen (NL)
- Max Delbrück Center (DE)
- Harvard University (US)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- University College London (GB)
- Corresponding author
- Sungnak, Waradon
- ORCID
- Venue
- Nature Medicine
- Published
- 2020-04-23
- Volume
- 26
- Issue
- 5
- Pages
- 681-687
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC8637938
- OpenAlex
- W3011483298
- Cited by
- 2,501
- References
- 59
- Citations by year
- 2026: 53 · 2025: 105 · 2024: 140 · 2023: 265 · 2022: 454 · 2021: 814 · 2020: 664
- FWCI
- 71.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Medicine (publishedVersion, other-oa)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) (acceptedVersion)
- PubMed Central (acceptedVersion)
- arXiv (Cornell University) (submittedVersion)
- Työväentutkimus Vuosikirja (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion, public-domain)
- Apollo (University of Cambridge) (submittedVersion)
- HAL (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Site cant be reached (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Apollo
- Funders
- U.S. Department of Defense (W81XWH1910416)
- Howard Hughes Medical Institute
- U.S. Department of Veterans Affairs
- Bill and Melinda Gates Foundation
- Richard and Susan Smith Family Foundation
- Massachusetts General Hospital
- Yale University
- Vanderbilt University
- Massachusetts Institute of Technology
- Memorial Sloan-Kettering Cancer Center
- Northwestern University
- School of Medicine, Boston University
- Arizona State University
- Helsingin Yliopisto
- University of Washington
- Deutsches Zentrum für Infektionsforschung
- Wellcome Trust (211276/Z/18/Z, 211276/D/18/Z, 108082/A/15/Z, #MR/R006237/1, WT206194, 107931/Z/15/Z, GINOP-2.3.2-15-2016-00026, WT211276/Z/18/Z)
- Deutsches Zentrum für Herz-Kreislaufforschung
- European Bioinformatics Institute
- National Jewish Health
- Vanderbilt University Medical Center
- European Molecular Biology Laboratory
- Broad Institute
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- Manton Foundation
- University of Alberta
- Cancer Research UK
- National Institute for Health and Care Research (PB-PG-1215-20037, CL-2017-14-001)
- British Heart Foundation (SP/19/1/34461, PG/16/47/32156)
- Cystic Fibrosis Trust (VIA 028)
- Academy of Medical Sciences (SGL019\1071)
- Imperial College London (H2020)
- University College London
- Newcastle University
- European Commission (2018-342, GINOP‐2.3.2‐15‐2016‐00037, 874656, GINOP-2.3.2-15-2016-00006, H2020)
- Rosetrees Trust
- National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC/T2T0419, NC/N001540/1)
- National Research Foundation
- Deutsche Forschungsgemeinschaft (347286815, DK043351, EXC2151/1, EXC 2151, 329123747, 390873048)
- Agence Nationale de la Recherche (ANR‐10‐INBS‐09‐03, ANR- 10-INBS-09, ANR‐19, ANR-19-CE14, ANR-19-CE14-0027, ANR-10, 10-INBS-09, -15-IDEX-01, ANR‐15‐IDEX‐01)
- Fondation Leducq
- Rijksuniversiteit Groningen
- University of New South Wales
- National Natural Science Foundation of China (31871370)
- Catholic University of Korea
- Cancerfonden (2019-)
- Fondation pour la Recherche Médicale (DEQ20180339158)
- National Research Foundation of Korea
- Karolinska Institutet
- National Science and Technology Development Agency
- Kungliga Tekniska Högskolan
- Vetenskapsrådet (2018-)
- Thailand Research Fund
- Centre National de la Recherche Scientifique
- Universitair Medisch Centrum Groningen
- Deutsches Zentrum für Neurodegenerative Erkrankungen
- Medizinischen Hochschule Hannover
- Rheinische Friedrich-Wilhelms-Universität Bonn
- Stockholms Universitet
- Science for Life Laboratory
- Conseil Départemental des Alpes Maritimes (2016-294DGADSH-CV)
- Deutsches Zentrum für Lungenforschung
- National Centre for the Replacement Refinement and Reduction of Animals in Research (NC/N001540/1)
- Ministerie van Economische Zaken en Klimaat
- Berlin Institute of Health
- National Institutes of Health (1r56hl135124-01, H2020, AG‐049665, DK 043351, AI135964)
- Directorate for Biological Sciences
- School of Medicine, Duke University
- School of Medicine, Stanford University
- University of California, San Diego
- Harvard Stem Cell Institute
- Feinberg School of Medicine
- Medical School, University of Michigan
- Horizon 2020 Framework Programme (874656, GINOP-2.3.2)
- Klarman Cell Observatory, Broad Institute
- Medical Research Council (MC_PC_17230, MR/R015635/1, MR/P009581/1, MC_PC_12009, MR/R006237/1, MR/K017047/1, MR/S005579/1)
- Engineering and Physical Sciences Research Council (TS/H001220/1)
- Biotechnology and Biological Sciences Research Council (BB/T004460/1, BB/V01126X/1)
- National Health and Medical Research Council
- Faculty of Medical Sciences, Newcastle University
- European Regional Development Fund (GINOP‐2.3.2‐15‐2016‐00006, H2020, GINOP-2.3.2-15-2016-00037, GINOP-2.3.2-15-2016-00026)
- NIHR Newcastle Biomedical Research Centre
- Helmholtz Zentrum München
- NIHR Cambridge Biomedical Research Centre
- National Institute on Aging (P01AG049665)
- National Heart, Lung, and Blood Institute (HL135124, R01HL146557, U01HL148856, R56 HL135124, K08HL130595, K08HL146943, HL148856, U01HL145567, R01HL145372, R01HL127349)
- National Institute of Allergy and Infectious Diseases (U24AI118672, U19AI135964)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK043351)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R24HD000836)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Keywords
- SARS-CoV-2, viral entry factors, ACE2, TMPRSS2, nasal epithelial cells, innate immunity, respiratory epithelium, corneal epithelium, intestinal epithelium, tissue tropism, COVID-19 pandemic, single-cell transcriptomics, gene co-expression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
